Non-User Fee Dollars Increased In US FDA’s Updated FY 2026 Budget Request

 
• By Derrick Gingery
  
FDA Commissioner Martin Makary answers questions from a Senate Appropriations subcommittee. (Screenshot of Senate Broadcast)

More from Legislation

More from Agency Leadership